New sugar a treat for diabetes treatment

December 20, 2011
Dr Simeonovic and Professor Parish. Photo by Karen Edwards.

(Medical Xpress) -- Researchers from The Australian National University have discovered a new treatment for Type-1 diabetes – an autoimmune disease which currently affects some 130,000 Australians.

Dr Charmaine Simeonovic and Professor Christopher Parish from The John Curtin School of Medical Research have identified a previously unknown process which causes destruction of the insulin-producing beta cells in the pancreas. The researchers found that the insulin-producing cells need a complex sugar, heparan sulphate, for their survival.

Beta cells are one of five cell types found in the pancreas and produce insulin – a hormone which helps move sugars from the food we eat into cells in our body for energy. In the human body’s immune system destroys these cells by mechanisms that are not well understood.

Dr Simeonovic said that their research has shown that beta cells found in the pancreas need heparan sulphate for their survival and without it they die.

“We’ve discovered that replacement of heparan sulphate in the beta cells rescues the cells from dying and prevents them from damage caused by oxidation. This new work has identified heparan sulphate depletion in beta cells as a major cause of beta cell death.

“We attribute this cell death to loss of the beta cells’ normal defence against damage by oxidation caused by free radicals, or highly chemically reactive atoms, molecules or ions.”

The study also revealed that the autoimmune cells in the immune system damage beta cells by producing the enzyme heparanase, which degrades heparan sulphate in beta cells.

“Treatment with a heparanase inhibitor, PI-88, was shown to preserve heparan sulphate in the of the pancreas and protect against Type-1 diabetes,” said Dr Simeonovic.

“This has revealed a new understanding of the development of Type-1 and has identified a new therapeutic strategy for preventing progression of the autoimmune disease and associated complications.”

Professor Parish added that the researchers are already taking the medical breakthrough from the bench to the bedside.

“We’re developing new drugs to take advantage of this discovery. A start-up biotechnology company, Beta Therapeutics, has been set up to translate our findings to the clinic,” said Professor Parish.

The researchers’ breakthrough has been published today in The Journal of Clinical Investigation.

Explore further: Connexins: Providing protection to cells destroyed in Type 1 diabetes

Related Stories

Recommended for you

As cells age, the fat content within them shifts

January 19, 2017

As cells age and stop dividing, their fat content changes, along with the way they produce and break down fat and other molecules classified as lipids, according to a new University at Buffalo study.

What causes sleepiness when sickness strikes

January 19, 2017

It's well known that humans and other animals are fatigued and sleepy when sick, but it's a microscopic roundworm that's providing an explanation of how that occurs, according to a study from researchers at the Perelman School ...

Soft robot helps the heart beat

January 18, 2017

Harvard University and Boston Children's Hospital researchers have developed a customizable soft robot that fits around a heart and helps it beat, potentially opening new treatment options for people suffering from heart ...

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

PPihkala
not rated yet Dec 20, 2011
I think the next obvious thing to study would be why some people have too much heparanase in their pancreas and how that can be modified without drugs.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.